Skip to main navigation
Main Menu
Header Nav
Our science
our pipeline
disease focus: HAE
HAE community
clinical trials
About us
about us
join us
Contact
Investors
Investor Menu
IR Nav
Overview
News & Events
News Releases
Events & Presentations
Publications
Financials
SEC Filings
Stock
Stock Performance
Analyst Coverage
Corporate Governance
Governance Documents
Management Team
Board of Directors
Committee Composition
Resources
FAQ
Contact Us
Email Alerts
Event Details
Breadcrumb
Home
/
Investor Relations
/
Events & Presentations
/ 2022 Bradykinin Symposium
2022 Bradykinin Symposium
Sep 16, 2022 at 10:45 AM CEST
Supporting Materials
Development of PHA121 for On-Demand and Prophylactic Treatment of HAE
926.6 KB
Toolkit
Print Page
Print Page
Email Alerts
Email Alerts
IR Contacts
IR Contacts
